investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Healthcare ↓1.28   Biology ↓1.28   Disease: Infectious ↓1.28 «See more»   Disease: Cardiovascular ↑0.76   Biopharma ↑1   Medicine ↑1.27

Disease: Cardiovascular stock segment: trending tickers

AMRN Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share -0.07% up -0.57% 0.5 + Country: Ireland, Medicine, Disease: Cardiovascular

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/897448/000119312526188940/0001193125-26-188940-index.htm
10-Q - AMARIN CORP PLCUK (0000897448) (Filer)
+ My List
CYTK Cytokinetics, Incorporated - Common Stock 5.49% up 4.61% 0.88 + Medicine, Disease: Cardiovascular

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm
10-K - CYTOKINETICS INC (0001061983) (Filer)
+ My List
ESPR Esperion Therapeutics, Inc. - Common Stock 1% 1% 0 + Medicine, Biopharma, Disease: Cardiovascular

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1434868/000162828026023196/0001628280-26-023196-index.htm
8-K - Esperion Therapeutics, Inc. (0001434868) (Filer)
+ My List
QTRX Quanterix Corporation - Common Stock -1.28% up -2.24% 0.96 + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1503274/000150327426000011/0001503274-26-000011-index.htm
8-K - Quanterix Corp (0001503274) (Filer)
+ My List
CVRX CVRx, Inc. - Common Stock -1.33% up -2.26% 0.93 + Disease: Cardiovascular, Medicine

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1376139/000137613926000028/0001376139-26-000028-index.htm
10-Q - CVR ENERGY INC (0001376139) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.